Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses.
The baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) can infect a variety of mammalian cells, as well as insect cells, facilitating its use as a viral vector for gene delivery into mammalian cells. Glycoprotein gp64, a major component of the budded AcMNPV envelope, is involved in viral entry into cells by receptor-mediated endocytosis and subsequent membrane fusion. We examined the potential production of pseudotype baculovirus particles transiently carrying ligands of interest in place of gp64 as a method of ligand-directed gene delivery into target cells. During amplification of a gp64-null pseudotype baculovirus carrying a green fluorescent protein gene in gp64-expressing insect cells, however, we observed the high-frequency appearance of a replication-competent virus incorporating the gp64 gene into the viral genome. To avoid generation of replication-competent revertants, we prepared pseudotype baculoviruses by transfection with recombinant bacmids without further amplification in the gp64-expressing cells. We constructed gp64-null recombinant bacmids carrying cDNAs encoding either vesicular stomatitis virus G protein (VSVG) or measles virus receptors (CD46 or SLAM). The VSVG pseudotype baculovirus efficiently transduced a reporter gene into a variety of mammalian cell lines, while CD46 and SLAM pseudotype baculoviruses allowed ligand-receptor-directed reporter gene transduction into target cells expressing measles virus envelope glycoproteins. Gene transduction mediated by the pseudotype baculoviruses could be inhibited by pretreatment with specific antibodies. These results indicate the possible application of pseudotype baculoviruses in ligand-directed gene delivery into target cells.
Kitagawa
Yoshinori
Y
Research Center for Emerging Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Tani
Hideki
H
Limn
Chang Kwang
CK
Matsunaga
Tomoko M
TM
Moriishi
Kohji
K
Matsuura
Yoshiharu
Y
D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D017353:Gene Deletion; D018390:Gene Targeting / Q000379:methods*; D017930:Genes, Reporter; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006023:Glycoproteins / Q000235:genetics / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D007136:Immunoglobulins / Q000235:genetics / Q000378:metabolism; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D017924:Nucleopolyhedroviruses / Q000235:genetics* / Q000502:physiology; D000077183:Occlusion Body Matrix Proteins; D011401:Promoter Regions, Genetic; D011956:Receptors, Cell Surface; D011995:Recombination, Genetic; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D014161:Transduction, Genetic; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism; D014760:Viral Fusion Proteins / Q000096:biosynthesis / Q000235:genetics; D014764:Viral Proteins / Q000235:genetics; D015678:Viral Structural Proteins
D015703:Antigens, CD; C028391:G protein, vesicular stomatitis virus; D006023:Glycoproteins; D007136:Immunoglobulins; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D000077183:Occlusion Body Matrix Proteins; D011956:Receptors, Cell Surface; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins; D014764:Viral Proteins; D015678:Viral Structural Proteins; C009829:polyhedrin protein, Nucleopolyhedrovirus; D049452:Green Fluorescent Proteins; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2489-93
7708671
Gene. 1991 Dec 15;108(2):193-9
1660837
Arch Virol. 2000;145(1):159-64
10664413
J Virol. 1995 May;69(5):3049-58
7707532
J Immunol. 2003 Aug 1;171(3):1133-9
12874198
J Virol. 2004 May;78(9):4454-62
15078926
J Virol. 2004 May;78(9):4385-8
15078919
J Virol. 2003 Dec;77(24):13053-61
14645562
J Virol. 1992 Nov;66(11):6829-35
1404622
Nature. 2000 Aug 24;406(6798):893-7
10972291
Virology. 1988 Dec;167(2):407-13
3059676
J Gen Virol. 1997 Oct;78 ( Pt 10):2657-64
9349488
Virology. 1983 Feb;125(1):107-17
6402854
J Virol. 2003 Sep;77(17):9183-91
12915534
Cell. 1983 Feb;32(2):639-46
6297804
J Virol. 2001 May;75(9):4399-401
11287589
J Virol. 1999 Jul;73(7):5473-80
10364295
FEBS Lett. 1992 Jun 15;304(2-3):221-4
1618326
J Virol. 1999 Dec;73(12):9944-51
10559307
J Virol. 2001 Mar;75(6):2544-56
11222677
Virology. 2001 Jan 5;279(1):343-53
11145915
Virology. 1999 Feb 15;254(2):297-314
9986796
Trends Biotechnol. 2002 Apr;20(4):173-80
11906750
J Virol. 2000 Jun;74(11):5066-74
10799580
J Gen Virol. 1987 May;68 ( Pt 5):1233-50
3553425
Cell. 1991 Oct 4;67(1):117-30
1913813
J Virol. 1993 Oct;67(10):6025-32
8371352
Nat Med. 2003 Nov;9(11):1408-12
14566335
Int J Biochem Cell Biol. 1999 Nov;31(11):1255-60
10605818
Mol Microbiol. 1997 Aug;25(4):639-47
9379894
J Virol. 1999 Aug;73(8):6937-45
10400792
J Virol. 1995 Apr;69(4):2583-95
7533858
J Virol. 2004 Feb;78(4):1792-9
14747544
J Biol Chem. 1999 Jan 22;274(4):2038-44
9890962
J Virol. 1996 Jul;70(7):4607-16
8676487
Virology. 1983 Mar;125(2):432-44
6340331
Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10099-103
7479733
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2348-52
8637876
Virology. 1985 May;143(1):185-95
18639849
J Mol Med (Berl). 1996 Apr;74(4):205-12
8740651
Virology. 1984 Mar;133(2):354-62
18639808
Biochem Biophys Res Commun. 2001 Jun 15;284(3):777-84
11396970
J Virol. 2004 Jun;78(12):6370-80
15163730
Cell. 1999 Dec 23;99(7):817-27
10619434
Blood. 2002 Feb 1;99(3):957-65
11806999
J Biotechnol. 2002 May 23;95(3):269-75
12007867
J Biol Chem. 1995 Jun 23;270(25):15148-52
7541036
J Virol. 2004 Oct;78(20):10920-6
15452212
J Virol. 2003 Jun;77(11):6265-73
12743283
J Gen Virol. 2000 Jun;81(Pt 6):1593-9
10811943
Biochem J. 1984 Feb 15;218(1):1-10
6370236
J Virol. 2002 Jun;76(11):5729-36
11992001
Virology. 1982 Aug;121(1):168-74
6180551
J Immunol. 1991 Nov 1;147(9):3005-11
1717583
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):127-32
9874783
Hum Gene Ther. 1997 Nov 20;8(17):2011-8
9414250
Mol Immunol. 2003 Sep;40(2-4):109-23
12914817
J Virol. 2000 Jan;74(1):305-11
10590118
Cell. 1993 Oct 22;75(2):295-305
8402913
Technol Cancer Res Treat. 2004 Feb;3(1):77-84
14750896
Virology. 1999 Jun 5;258(2):455-68
10366584
Virology. 2001 Jan 5;279(1):9-21
11145884
J Virol. 1996 Dec;70(12):8391-401
8970960
J Virol. 2002 May;76(10):4891-900
11967306
J Virol. 1991 Jul;65(7):3625-32
2041087
J Virol. 2003 Sep;77(18):9799-808
12941888
Virology. 1994 Aug 1;202(2):586-605
8030224
Virology. 1995 Jun 1;209(2):592-603
7778291
Curr Opin Mol Ther. 2001 Oct;3(5):464-7
11699890
Cancer Res. 2002 Aug 15;62(16):4656-62
12183422